Institut de Cancerologie de L'Ouest

Institut de Cancerologie de L'Ouest is a research organisation in Angers, France that has taken part in 7 EU-funded projects since 2013, receiving €1.6M in EU funding and leading 1 as coordinator.

EU funding received€1.6M
EU projects7
As coordinator1
Running now5
First EU project2013
Latest project2024
CountryFrance
EU registration (PIC)953105802
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Institut de Cancerologie de L'Ouest's own share of each project, not the project's full budget.

  • Horizon Europe€1.1M · 3 projects
  • Horizon 2020€275k · 2 projects
  • EU4Health Programme (EU4H)€272k · 1 project
  • FP7 (2007 to 2013)€0 · 1 project

Projects

7 EU-funded projects, newest first. Institut de Cancerologie de L'Ouest led 1 of them as coordinator. Each links to the official record.

  • Thera4CarePartner

    THERANOSTICS ECOSYSTEM FOR PERSONALISED CARE

    Horizon Europe · 2024–2029 · Project on CORDIS ↗

    €632ktheir share
  • Accelerate.EUPartner

    Elevating the Future of Cancer care with Alpha Theranostics

    Horizon Europe · 2024–2029 · Project on CORDIS ↗

    €469ktheir share
  • EUnetCCC JAAssociated partner

    The European Comprehensive Cancer Centre Network

    EU4Health Programme (EU4H) · 2024–2028 · Project on the EU portal ↗

    €272ktheir share
  • e-QuoLAssociated partner

    e-health tools to promote Equality in Quality of Life for childhood to young adulthood cancer patients, survivors and their families - a PanEuropean project supported by PanCare and Harmonic consortia

    Horizon Europe · 2024–2027 · Project on CORDIS ↗

  • OPTIMAPartner

    Optimal treatment for patients with solid tumours in Europe through Artificial intelligence

    Horizon 2020 · 2021–2027 · Project on CORDIS ↗

    €90ktheir share
  • PredAlgoBCCoordinator

    Machine learning prediction for breast cancer therapy

    Horizon 2020 · 2019–2021 · Project on CORDIS ↗

    €185ktheir share
  • CARESSPartner

    A new methodology based on an advanced molecular probe for early detection of DPD enzyme deficiency in oncological patients, also enabling a personalised and effective drug management""

    FP7 (2007 to 2013) · 2013–2015 · Project on CORDIS ↗

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • artificial intelligence
  • breast cancer
  • data mining
  • eHealth
  • enzymes
  • machine learning
  • mathematics
  • mortality
  • nutrition
  • oncology
  • personalized medicine
  • radiation chemistry
  • skin cancer
  • social inequalities

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime